Fortis Healthcare Announces Mumbai Investor Roadshow

Fortis Healthcare announced it will host an investor and analyst roadshow in Mumbai on April 27th and 28th, 2026. Management plans to engage with investors daily from 9:00 AM to 7:00 PM IST to discuss general business updates and current industry trends. The company emphasized that no Unpublished Price Sensitive Information (UPSI) will be shared during these meetings. The schedule is subject to change due to unforeseen circumstances.

Strengthening Investor Relations

Investor roadshows serve as vital platforms for companies to directly communicate their strategies, performance, and future outlook to the financial community. For Fortis Healthcare, this event offers a chance to build trust and provide investors and analysts with a clearer picture of its business operations and the broader healthcare sector. While no new material information is expected, the direct engagement aims to enhance market awareness and investor confidence.

Fortis Healthcare's Business and History

Fortis Healthcare is a major integrated healthcare provider in India, operating around 36 hospitals and over 400 diagnostics centers (including Agilus Diagnostics), with approximately 6,000 operational beds. The company has navigated significant challenges, including a governance crisis between 2015 and 2018 marked by allegations of fund diversion and legal disputes. In 2018, IHH Healthcare acquired a significant stake, providing a capital injection and a strategic shift towards scale and professional management.

Recent developments include disclosures for ₹1,550 crore in debt securities and a credit rating upgrade to CRISIL AA+. Fortis is also expanding, aiming to add 1,500-2,000 beds by the end of 2027 through brownfield projects and facility integration. Past issues included SEBI imposing penalties totaling Rs 38.75 crore on 32 entities in May 2022 related to alleged fund diversion. Former promoters Malvinder and Shivinder Singh faced legal battles, receiving a six-month jail term in September 2022. Fortis also acquired its trademark for Rs 200 crore in April 2025.

Potential Schedule Adjustments

Fortis Healthcare has noted that the timings and schedule of the roadshow meetings may change due to unforeseen circumstances.

Market Position Among Peers

Fortis Healthcare competes in India's crowded hospital sector against key players like Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd, Narayana Hrudayalaya Ltd, and Global Health Ltd.

As of Q2 FY26, Fortis had roughly 5,554-5,800 beds, positioning it behind Apollo Hospitals (over 8,000 beds) but ahead of Max Healthcare (3,454 beds). In FY25, Fortis reported revenue of Rs 7,783 crore, exceeding Max Healthcare (Rs 7,028 crore) but trailing Apollo Hospitals (Rs 21,794 crore). Foreign ownership in Fortis was around 27.9% in December 2025, lower than its main competitors.

Key Growth and Margin Targets

The company plans to add approximately 1,500 to 2,000 beds by the end of 2027 through brownfield expansion. Management projects revenue growth between 13% and 15% for FY2025-26. Fortis Healthcare also targets a consolidated operating profit margin of 24-25% over the next two years (FY26–FY27).

Monitoring Future Developments

Investors should watch for any official updates regarding changes to the roadshow schedule. Monitoring analyst and investor feedback post-event will be key, particularly concerning any business updates shared. It will also be important to track future company disclosures for strategic initiatives or financial performance changes discussed during the roadshow.